EIN 84-2240648

CureSHANK

IRS 501(c) type
501(c)(3)
Num. employees
0
Year formed
2019
Most recent tax filings
2024-12-01
Description
CureSHANK accelerates treatments for Phelan-McDermid syndrome by funding research, bridging gaps to clinical trials, and fostering collaboration among scientific stakeholders.
Total revenues
$597,811
2024
Total expenses
$528,155
2024
Total assets
$1,118,841
2024
Num. employees
0
2024

Program areas at CureSHANK

CureSHANK will bring the scientific community together by organizing scientific symposium and other meetings. With our scientific stakeholders, we will develop a research roadmap to a cure for SHANK-related disorders. We will also serve as an honest broker to enable collaboration among SHANK researchers and coordination of their projects to improve the speed and efficiency of research.
CureSHANK will advocate for increased funding of SHANK research by other stakeholders and strategize with researchers on initiatives, such as seed grants, that could help attract research investment by other funders.
CureSHANK will fund targeted research studies, including scientific projects that elucidate the underlying disease mechanisms, that identify and validate targets for drug development, and that de-risk promising drug targets. CureSHANK will also fund certain promising clinical trials readiness initiatives. These activities are needed to increase the number of drug targets moving from academic research labs into successful industry-sponsored clinical trials.

Grants made by CureSHANK

GranteeAmount
University of Utah$62,474
Icahn School of Medicine at Mount Sinai$10,000

Who funds CureSHANK

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Community Foundation for BrevardHealth & Wellness$100,000
Fidelity Investments Charitable Gift FundFor Grant Recipient's Exempt Purposes$27,500
Resnick FoundationDonee's Tax Exempt Purpose$10,000
...and 8 more grants received

Financials for CureSHANK

RevenuesFYE 12/2024
Total grants, contributions, etc.$586,766
Program services$0
Investment income and dividends$11,045
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$597,811
Data update history
September 22, 2026
Received grants
Identified 2 new grant, including a grant for $10,115 from American Online Giving Foundation
June 20, 2026
Received grants
Identified 4 new grant, including a grant for $10,000 from Jewish Communal Fund
April 7, 2026
Posted financials
Added Form 990 for fiscal year 2024
February 27, 2026
Updated personnel
Identified 3 new personnel
February 4, 2026
Used new vendors
Identified 2 new vendors, including , and
Nonprofit Types
Grantmaking organizationsDisease research fundraisersMedical research organizationsCharities
Issues
HealthDiseases and disorders
Characteristics
Legally formed as corporationConducts researchOperates internationallyTax deductible donationsNo full-time employeesAccepts online donations
General information
Address
11777 San Vicente Blvd 500
Los Angeles, CA 90049
Metro area
Los Angeles-Long Beach-Anaheim, CA
County
Los Angeles County, CA
Website URL
cureshank.org/ 
Phone
(310) 409-8060
IRS details
EIN
84-2240648
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2019
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H90: Medical Specialty Research
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
May Operate or Solicit for Charitable Purposes
Charity Registration status
Current
FTB status revoked
Not revoked
AG Registration Number
CT0281327
FTB Entity ID
4294636
AB 488 data last updated ("as-of") date
2026-08-19
Free account sign-up

Want updates when CureSHANK has new information, or want to find more organizations like CureSHANK?

Create free Cause IQ account